PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Hepatology10.3350/kjhep.2011.17.3.2202011173220Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosisKyung Hoon Kim, Byoung Kuk Jang, Woo Jin Chung, Jae Seok Hwang, Young Oh Kweon, Won Young Tak, Heon Ju Lee, Chang Hyeong Lee, Jeong Ill Suhhttp://synapse.koreamed.org/pdf/10.3350/kjhep.2011.17.3.220, http://synapse.koreamed.org/DOIx.php?id=10.3350/kjhep.2011.17.3.220, http://www.e-cmh.org/upload/pdf/kjhep-17-220.pdf
Value in Health10.1016/j.jval.2012.03.7512012154A139PGI24 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Retreatment of Patients with Chronic Hepatitis C Virus Genotype I InfectionM. Fonseca, G. Tannus, E. Parisihttps://api.elsevier.com/content/article/PII:S1098301512008169?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301512008169?httpAccept=text/plain
Value in Health10.1016/j.jval.2012.08.7702012157A329PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I InfectionM. Fonseca, V. Garran, G.T. Araujohttps://api.elsevier.com/content/article/PII:S1098301512024837?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301512024837?httpAccept=text/plain
Gastroenterology10.1053/j.gastro.2015.02.02820151484e11-e12Exam 1: The Combination of Simeprevir and Sofosbuvir Is More Effective Than That of Peginterferon, Ribavirin, and Sofosbuvir for Patients With Hepatitis C–Related Child's Class A Cirrhosishttps://api.elsevier.com/content/article/PII:S0016508515002504?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0016508515002504?httpAccept=text/xml
Journal of Human Genetics and Genomics10.5812/jhgg.65255201711The Impact of Interleukin-28B rs12979860 Polymorphism on Peginterferon-alpha and Ribavirin Combination Therapy in Iranian Patients with Hepatitis C Virus Genotype 1 InfectionMahboubeh Hajiabdolbaghi, Reza Shahsiah, Mahsa Motavaf, Tabasom Zavarihttps://jhgg.kowsarpub.com/cdn/dl/a68a367a-3d51-11e8-b39d-834f95dea273, https://sites.kowsarpub.com/jhgg/articles/65255.html
Journal of Hepatology10.1016/s0168-8278(05)81985-3200542209574 Association between liver histology, viral kinetics and outcome of therapy with peginterferon α-2a combination therapy with ribavirin in interferon naive patients with chronic hepatitis Chttps://api.elsevier.com/content/article/PII:S0168827805819853?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827805819853?httpAccept=text/plain
Gastroenterology10.1016/s0016-5085(11)63936-x20111405S-950Peginterferon ALPHA-2A (40KD) Plus Ribavirin for the Treatment of Patients With Chronic Hepatitis C (CHC) and Compensated Liver Cirrhosis in JapanNamiki Izumi, Shuichi Kaneko, Shuhei Nishiguchi, Masatoshi Kudo, Michio Sata, Masao Omatahttps://api.elsevier.com/content/article/PII:S001650851163936X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S001650851163936X?httpAccept=text/plain
Gastroenterology10.1053/j.gastro.2014.12.02720151484762-770.e2The Combination of Simeprevir and Sofosbuvir Is More Effective Than That of Peginterferon, Ribavirin, and Sofosbuvir for Patients With Hepatitis C–Related Child's Class A CirrhosisBrian L. Pearlman, Carole Ehleben, Michael Perryshttps://api.elsevier.com/content/article/PII:S0016508514015790?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0016508514015790?httpAccept=text/xml
Surgical Endoscopy10.1007/s00464-009-0653-62009243680-685Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenismTomohiko Akahoshi, Morimasa Tomikawa, Daisuke Korenaga, Koji Ikejiri, Motonori Saku, Kenji Takenakahttp://link.springer.com/content/pdf/10.1007/s00464-009-0653-6.pdf, http://link.springer.com/article/10.1007/s00464-009-0653-6/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00464-009-0653-6
Yearbook of Gastroenterology10.1016/s0739-5930(08)70206-x20072007258-259Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled studyK.M. Changhttps://api.elsevier.com/content/article/PII:S073959300870206X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S073959300870206X?httpAccept=text/plain